Kalaris Therapeutics (KLRS)
NASDAQ:KLRS
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Mar 23, 2026 | xxxxxxxxxxxxx | $12869 | |
Feb 17, 2026 | xxxxxxxxxxxxx | $5000006 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2025 | xxxxxxxxxxxxx | $844000 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 19,677,546 | Insider | 85.82% | 113,932,991 | |
| 12,948,081 | Insider | 56.47% | 74,969,389 | |
| 504,000 | Insider | 2.20% | 2,918,160 | |
| 352,800 | Insider | 1.54% | 2,042,712 | |
| 249,346 | Institution | 1.09% | 1,443,713 | |
| 249,346 | Institution | 1.09% | 1,443,713 | |
| 100,000 | Institution | 0.44% | 579,000 | |
| 87,426 | Institution | 0.38% | 506,197 | |
| 74,608 | Institution | 0.33% | 431,980 | |
| 68,796 | Institution | 0.30% | 398,329 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 249,346 | Institution | 1.09% | 1,443,713 | |
| 74,608 | Institution | 0.33% | 431,980 | |
| 68,796 | Institution | 0.30% | 398,329 | |
| 30,838 | Institution | 0.13% | 178,552 | |
| 22,500 | Institution | 0.10% | 130,275 | |
| 8,954 | Institution | 0.04% | 51,844 | |
| 6,002 | Institution | 0.03% | 34,752 | |
| 5,300 | Institution | 0.02% | 30,687 | |
| 4,083 | Institution | 0.02% | 23,641 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 176,727 | Institution | 0.77% | 1,848,564 | |
| 87,426 | Institution | 0.38% | 471,226 | |
| 72,619 | Institution | 0.32% | 759,595 | |
| 8,699 | Institution | 0.04% | 46,888 | |
| 384 | Institution | <0.01% | 1,065 | |
| 255 | Institution | <0.01% | 707 |
FAQ
Who Owns Kalaris Therapeutics (KLRS)?
Currently, no data Available
What percentage of Kalaris Therapeutics (KLRS) stock is held by institutional investors?
Currently, no data Available
What percentage of Kalaris Therapeutics (KLRS) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Kalaris Therapeutics (KLRS)?
David Hallal owns the most shares of Kalaris Therapeutics (KLRS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.